Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David C Fajgenbaum
Siltuximab: A Targeted Therapy for Idiopathic Multicentric Castleman Disease
Immunotherapy
Oncology
Allergy
Immunology
Related publications
FDA Approval: Siltuximab for the Treatment of Patients With Multicentric Castleman Disease
Clinical Cancer Research
Cancer Research
Oncology
Predictors of Response to Anti-Il6 Monoclonal Antibody Therapy (Siltuximab) in Idiopathic Multicentric Castleman Disease: Secondary Analyses of Phase II Clinical Trial Data
British Journal of Haematology
Hematology
Long-Term Safety of Siltuximab in Patients With Idiopathic Multicentric Castleman Disease: A Prespecified, Open-Label, Extension Analysis of Two Trials
The Lancet Haematology
Hematology
Multicentric Castleman Disease: An Unusual Breast Lump
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Biologic Agents in the Treatment of Multicentric Castleman Disease
Turkish Thoracic Journal
Pulmonary
Respiratory Medicine
Clinicopathologic Characteristics of 342 Patients With Multicentric Castleman Disease in Japan
Modern Rheumatology
Medicine
Rheumatology
Human Herpesvirus-8 Negative Multicentric Castleman Disease in a Patient With Human Immunodeficiency Virus Treated With Highly Active Antiretroviral Therapy and Chemotherapy
Cureus
The Potential Clinical Benefit of Tocilizumab Therapy for Patients With HHV-8-infected AIDS-related Multicentric Castleman Disease: A Case Report and Literature Review
Cureus
Complete Remission in a Patient With Human Herpes Virus-8 Negative Multicentric Castleman Disease Using CHOP Chemotherapy
Cancer Research and Treatment
Cancer Research
Oncology
